These compounds may interact with:
Testosterone 17-beta-dehydrogenase 3
Potentially involved in: pseudohermaphroditism; carcinoma; androgen insensitivity syndrome; hypospadias; amenorrhea; prostate cancer; gynecomastia; cryptorchidism; hypothyroidism; infertility; prostatic neoplasms; disorders of sex development; male pseudohermaphroditism; ambiguous genitalia; 17-hydroxysteroid dehydrogenase deficiency; hypogonadotropic hypogonadism; hypogonadism, isolated hypogonadotropic; autosomal recessive predisposition; abnormality of metabolism/homeostasis; abnormality of the urethra
Disease data sourced from Pharos.